TrialJournal of the International Association of Providers of AIDS Care

Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal: A Cluster Randomized Trial.

Michael B Wohlfeiler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.